These dual-compound protocols provide flexible dosing of both GLP-1 agonists, allowing your provider to fine-tune your weight loss therapy without adding multiple injections or pills to your daily routine
Clinics like Florida Bariatric and Plastic Surgery MD and Florida Surgery And Weight Loss Center help patients check insurance eligibility for medications such as Mounjaro, Ozempic, Wegovy, and Zepbound, while offering telehealth consultations across Florida
UCO Medical Clinic 2100 E Hallandale Beach Blvd Suite 404, Hallandale Beach, FL 33009 Physician-supervised medical weight management, peptide therapy evaluations, metabolic assessment, body-composition monitoring, nutrition guidance, and ongoing follow-up for patients in Hallandale Beach and surrounding South Florida communities
Tselekidou A, Athanassakis I
Tirzepatide is a synthetic dual-agonist peptide that acts on both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, making it a widely used reference compound in metabolic and receptor-signalling research models
Long-acting preparations include lixisenatide (LIXI) and LIR, which are injected once a day
